In addition, NPY (neuropeptide Y), a member of the NPY family, is widely expressed in the central nervous system, and its receptor, NPY-1R, is associated with the proliferative potential of prostate cancer [31,32]. This evidence concerns the gene NPY1R and prostate carcinoma.